Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage III Malignant Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00512798
What this trial is testing

Bortezomib and Temozolomide in Treating Patients With Advanced Refractory Solid Tumors or Melanoma

Who this might be right for
Brain and Central Nervous System TumorsMelanomaSolid Tumor
Vanderbilt-Ingram Cancer Center 47
Large-scale testing (Phase 3)Looking for participantsNCT05868707
What this trial is testing

OH2 Injection in Melanoma

Who this might be right for
Melanoma
Binhui Biopharmaceutical Co., Ltd. 340
Testing effectiveness (Phase 2)Study completedNCT00429312
What this trial is testing

Recombinant Vaccinia Virus to Treat Malignant Melanoma

Who this might be right for
Melanoma
Jennerex Biotherapeutics 10
Early research (Phase 1)Ended earlyNCT01744171
What this trial is testing

Vaccine Therapy in Treating Patients With Advanced Stage III-IV Melanoma

Who this might be right for
Recurrent MelanomaStage IIIB Skin MelanomaStage IIIC Skin Melanoma+1 more
Roswell Park Cancer Institute 10
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Large-scale testing (Phase 3)WithdrawnNCT01826864
What this trial is testing

Sargramostim or Hypertonic Saline Before Sentinel Lymph Node Biopsy in Treating Patients With Stage IB-II Melanoma

Who this might be right for
Stage IB MelanomaStage IIA MelanomaStage IIB Melanoma+1 more
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00027742
What this trial is testing

Temozolomide and Interferon Alfa in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT00897442
What this trial is testing

Collecting Tumor Samples From Patients With Gynecological Tumors

Who this might be right for
Borderline Ovarian Clear Cell TumorBorderline Ovarian Serous TumorCervical Adenocarcinoma+83 more
Gynecologic Oncology Group 275
Testing effectiveness (Phase 2)Study completedNCT04303169
What this trial is testing

Substudy 02C: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Stage III Melanoma Who Are Candidates for Neoadjuvant Therapy (MK-3475-02C/KEYMAKER-U02)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 146
Early research (Phase 1)Looking for participantsNCT07475572
What this trial is testing

Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma

Who this might be right for
Melanoma
Alvotech Swiss AG 120
Testing effectiveness (Phase 2)Study completedNCT00243529
What this trial is testing

Peptide-pulsed vs. RNA-transfected Dendritic Cell Vaccines in Melanoma Patients

Who this might be right for
Melanoma Stage III or IV
Radboud University Medical Center 64
Testing effectiveness (Phase 2)Ended earlyNCT05764395
What this trial is testing

Rigosertib Plus Pembrolizumab in Treating Patients With Unresectable/Metastatic Melanoma Refractory to PD-1 Inhibitors

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Melanoma+2 more
Vanderbilt-Ingram Cancer Center 7
Early research (Phase 1)Ended earlyNCT00005841
What this trial is testing

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
University of Southern California 15
Testing effectiveness (Phase 2)Study completedNCT02094872
What this trial is testing

Molecularly Targeted Therapy in Treating Patients With BRAF Wild-type Melanoma That is Metastatic

Who this might be right for
Recurrent MelanomaStage IIIA MelanomaStage IIIB Melanoma+2 more
Yale University 49
Testing effectiveness (Phase 2)Study completedNCT00059800
What this trial is testing

Boron Neutron Capture Therapy in Treating Patients With Melanoma

Who this might be right for
Melanoma (Skin)
Beth Israel Deaconess Medical Center